S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenström’s Macroglobulinemia (2013/12/4)|
|ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2013 RESULTS (2014/3/11)|
|ChipMOS TAIWAN COMMENCES SHARE SUBSCRIPTION PROCESS FOR TWSE IPO LISTING (2014/3/28)|
|ChipMOS REPORTS FEBRUARY 2014 REVENUE (2014/3/10)|
|ChipMOS TAIWAN TO COMMENCE TRADING ON TAIWAN STOCK EXCHANGE ON APRIL 11, 2014 (2014/4/1)|
|ChipMOS TAIWAN ANNOUNCES PRICING OF SHARE SUBSCRIPTION (2014/4/3)|
|ChipMOS REPORTS MARCH 2014 AND 1Q14 REVENUE (2014/4/10)|
|ALERT: ChipMOS TAIWAN COMMENCES TWSE TRADING UNDER TICKER 8150 ON APRIL 11, 2014 (2014/4/11)|
|Idera Pharmaceuticals Announces Positive Top-line Data in Phase 2 Trial of IMO-8400 (2014/3/28)|
|Idera Presents Preclinical Data at AACR Showing IMO-8400 Inhibits Tumor Growth and Survival Signaling in B-cell Lymphoma Cells with Oncogenic MYD88 L265P Mutation (2014/4/7)|
Click above to view more mutual fund data and stats for imos - Chipmos Technologies Bermuda Ltd.